Users Coming Off Weight-Loss Jabs Gain Back Weight at a Quadrupled Rate Than Dieters

Fresh analysis indicates that individuals who stop using new slimming jabs like Mounjaro or Wegovy can put back on shed pounds much more quickly than those who end conventional diet and exercise regimens.

Findings released in a prominent health publication shows that while obese individuals frequently drop substantial amounts of their total mass while using the jabs, the mass returns at an estimated rate of nearly a kilo each month after stopping.

"People buying such medications need to be cognizant of the danger of quick weight regain when the treatment is stopped," stated lead investigator Dr. Susan Jebb.

That rate of recovery means a reversion to starting mass within about 18 months.

Analyzing Treatments

The research, which examined 37 of trials involving over 9,000 of participants, contrasted the effects of these new drugs with conventional dieting.

The team point out that people who lose weight through lifestyle changes alone typically have a slower creep back—around 0.1 kg a month—after stopping.

Understanding the Fast Regain

Doctors propose the way of the injections explains the amplified regain.

These medications imitate a natural hormone called glucagon-like peptide-1, which moderates appetite.

"Artificially providing the hormone concentrations several times higher than the body's typical production may cause the body to generate a reduced amount of its own natural hormone, and may also lessen sensitivity to its effects," noted Dr. Adam Collins, a dietetics specialist.

"Withdrawal of this hormone supplement leads to appetite is unsuppressed, making binge eating far more likely."

An Ongoing Issue?

The NHS suggest the injections for individuals with weight-linked health risks, alongside prescribed lifestyle changes.

A number of clinicians contend that, given the likelihood of relapse, the treatment might need to be long-term.

This perspective is reinforced by drug manufacturers, who state that the findings "highlight the persistent nature of obesity," comparing it to managing diseases like diabetes.

User Accounts

People who have come off the medication report a sudden return of hunger.

"I experienced a trigger that goes on and I was suddenly ravenous," described one woman.

The struggle is worsened if patients have not established lasting dietary or behavioural modifications during treatment.

Significant Adoption

Survey data indicate that millions of adults in the UK have used these injections in the last 12 months, with desire being substantial.

• Use is more common among females than males.
• The 40s and 50s demographic shows the highest level of interest.
• A large proportion obtain the drugs through private prescriptions rather than public health services.

Ultimately, researchers emphasize that while these medications are powerful agents for weight loss, they are not a permanent fix and lasting health benefits relies on combined behavioural management.